In March 2025, the company announced new plans to get a immediate-to-buyer supplying of its Wegovy weight loss drug. The company proven a new pharmacy, named NovoCare, which would charge prospects $499 a month for access to the drug, lower than 50 % the expense of the drug as a result of other pharmaceutical distribution networks.[fifty three]A wei